NCT01024725

Evaluation of Pandemic Vaccination Campaign

Evaluation of a Vaccination Campaign With A(H1N1)v Pandemic Vaccines: a Prospective Cohort Study

• Status: Completed
• Phase: —
• Study type: Observational
• Enrollment: 3,518 (actual)
• Sponsor: Finnish Institute for Health and Welfare · Other Government
• Sex: All
• Age: 18 Years – 75 Years
• Healthy volunteers: Accepted

Summary

A cohort of 4000 community-dwelling adults is followed to evaluate the effectiveness of the Finnish national A(H1N1)v influenza vaccination campaign in preventing the first episode of laboratory-confirmed A(H1N1)v influenza. The safety of vaccination and the severity of the disease are followed primarily from health care registers. In a subgroup of 200 participants, the humoral and cellular immunogenicity of the vaccine will be studied.

Conditions

• Influenza Caused by the Novel A(H1N1)v Influenza Virus

Interventions

Type	Name	Description
OTHER	Follow-up	Nasopharyngeal/oropharyngeal and blood samples, interviews, questionnaires, register data

Timeline

• Start date: 2009-11-01
• Primary completion: 2010-04-01
• Completion: 2014-09-01
• First posted: 2009-12-03
• Last updated: 2014-09-25

Locations

1 site across 1 country: Finland